United States, ex rel. Deborah Sheldon, Petitioner v. Allergan Sales, LLC

22-593

June 30, 2023
Justices Order FCA Do-Overs After SuperValu Intent Ruling

The U.S. Supreme Court on Friday told the Fourth and Eleventh circuits to revisit closely watched whistleblower cases targeting units of Allergan and Abbott Laboratories, teeing up tests of the high court's new ruling on the meaning of intentional fraud under the False Claims Act.
June 12, 2023
DOJ Sees Far-Reaching Victory In High Court's FCA Ruling

The U.S. Supreme Court's ruling that faulty yet reasonable compliance views can trigger False Claims Act liability is undermining defense bar positions in wide-ranging contexts, including a new circuit split over FCA cases involving kickbacks, according to the U.S. Department of Justice.
January 05, 2023
The Hottest FCA Cases & Trends To Watch In 2023

The never-not-busy False Claims Act realm will be extra active in 2023 as the U.S. Supreme Court delivers at least one FCA opinion — and perhaps two or even three — in headliner cases during a year in which attorneys are also eyeing a new circuit split and emerging enforcement frontiers.
January 03, 2023
Health & Pharma Legal Clashes Didn't Take A Holiday Break

While many Americans were bringing glad tidings and popping bubbly, attorneys spent the final week of 2022 bringing lawsuits, appeals and other court filings of eye-popping significance for health care providers and drug companies in cases involving the False Claims Act, the opioid crisis and purported price-fixing schemes.